vs

Side-by-side financial comparison of Inogen Inc (INGN) and iQSTEL Inc (IQST). Click either name above to swap in a different company.

iQSTEL Inc is the larger business by last-quarter revenue ($84.2M vs $68.6M, roughly 1.2× Inogen Inc). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -14.9%). iQSTEL Inc produced more free cash flow last quarter ($-1.2M vs $-1.9M). Over the past eight quarters, iQSTEL Inc's revenue compounded faster (28.0% CAGR vs 4.2%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

iQSTEL Inc is a technology holding company operating three core segments: telecommunications, Internet of Things (IoT), and fintech. It offers connectivity services, smart IoT monitoring solutions, and digital financial tools, mainly serving small and medium-sized enterprises and retail customers in North and South American markets.

INGN vs IQST — Head-to-Head

Bigger by revenue
IQST
IQST
1.2× larger
IQST
$84.2M
$68.6M
INGN
Growing faster (revenue YoY)
INGN
INGN
+18.3% gap
INGN
3.4%
-14.9%
IQST
More free cash flow
IQST
IQST
$677.8K more FCF
IQST
$-1.2M
$-1.9M
INGN
Faster 2-yr revenue CAGR
IQST
IQST
Annualised
IQST
28.0%
4.2%
INGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INGN
INGN
IQST
IQST
Revenue
$68.6M
$84.2M
Net Profit
$-2.7M
Gross Margin
51.4%
3.5%
Operating Margin
-13.6%
-2.9%
Net Margin
-3.2%
Revenue YoY
3.4%
-14.9%
Net Profit YoY
-44.5%
EPS (diluted)
$-0.26
$-0.92

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
IQST
IQST
Q4 25
$68.6M
$84.2M
Q3 25
$79.1M
$102.9M
Q2 25
$79.2M
$72.2M
Q1 25
$68.5M
$57.6M
Q4 24
$66.3M
$98.9M
Q3 24
$74.9M
$54.2M
Q2 24
$74.4M
$78.6M
Q1 24
$63.1M
$51.4M
Net Profit
INGN
INGN
IQST
IQST
Q4 25
$-2.7M
Q3 25
$-5.3M
$-2.3M
Q2 25
$-4.2M
$-2.3M
Q1 25
$-6.2M
$-1.1M
Q4 24
$-1.9M
Q3 24
$-6.0M
$-773.0K
Q2 24
$-5.6M
$-2.0M
Q1 24
$-14.6M
$-580.2K
Gross Margin
INGN
INGN
IQST
IQST
Q4 25
51.4%
3.5%
Q3 25
52.2%
2.7%
Q2 25
52.2%
2.6%
Q1 25
53.1%
3.4%
Q4 24
54.7%
2.7%
Q3 24
55.2%
3.7%
Q2 24
57.4%
2.8%
Q1 24
54.5%
2.7%
Operating Margin
INGN
INGN
IQST
IQST
Q4 25
-13.6%
-2.9%
Q3 25
-9.0%
-0.5%
Q2 25
-7.7%
-0.9%
Q1 25
-11.2%
-1.0%
Q4 24
-17.2%
-0.3%
Q3 24
-10.4%
-0.1%
Q2 24
-9.5%
-0.4%
Q1 24
-25.8%
-0.4%
Net Margin
INGN
INGN
IQST
IQST
Q4 25
-3.2%
Q3 25
-6.7%
-2.3%
Q2 25
-5.2%
-3.3%
Q1 25
-9.0%
-2.0%
Q4 24
-1.9%
Q3 24
-8.0%
-1.4%
Q2 24
-7.5%
-2.5%
Q1 24
-23.1%
-1.1%
EPS (diluted)
INGN
INGN
IQST
IQST
Q4 25
$-0.26
$-0.92
Q3 25
$-0.20
$-0.68
Q2 25
$-0.15
$-0.82
Q1 25
$-0.25
$-0.44
Q4 24
$-0.41
$-1.19
Q3 24
$-0.25
$-0.40
Q2 24
$-0.24
$-0.90
Q1 24
$-0.62
$-0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
IQST
IQST
Cash + ST InvestmentsLiquidity on hand
$103.7M
$2.2M
Total DebtLower is stronger
$4.1M
Stockholders' EquityBook value
$192.2M
$16.3M
Total Assets
$298.6M
$51.1M
Debt / EquityLower = less leverage
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
IQST
IQST
Q4 25
$103.7M
$2.2M
Q3 25
$106.5M
$2.3M
Q2 25
$103.7M
$2.0M
Q1 25
$118.9M
$1.1M
Q4 24
$113.8M
$2.5M
Q3 24
$105.7M
$2.1M
Q2 24
$97.9M
$797.2K
Q1 24
$107.4M
$2.7M
Total Debt
INGN
INGN
IQST
IQST
Q4 25
$4.1M
Q3 25
$2.7M
Q2 25
$4.5M
Q1 25
$3.5M
Q4 24
$2.5M
Q3 24
$3.2M
Q2 24
$2.5M
Q1 24
$194.0K
Stockholders' Equity
INGN
INGN
IQST
IQST
Q4 25
$192.2M
$16.3M
Q3 25
$197.2M
$17.9M
Q2 25
$199.5M
$14.3M
Q1 25
$198.0M
$11.6M
Q4 24
$173.9M
$11.9M
Q3 24
$185.4M
$8.1M
Q2 24
$187.6M
$7.6M
Q1 24
$191.9M
$8.4M
Total Assets
INGN
INGN
IQST
IQST
Q4 25
$298.6M
$51.1M
Q3 25
$307.0M
$46.9M
Q2 25
$312.0M
$51.4M
Q1 25
$308.4M
$42.0M
Q4 24
$296.2M
$79.0M
Q3 24
$306.2M
$32.4M
Q2 24
$308.9M
$30.0M
Q1 24
$315.6M
$22.1M
Debt / Equity
INGN
INGN
IQST
IQST
Q4 25
0.25×
Q3 25
0.15×
Q2 25
0.31×
Q1 25
0.31×
Q4 24
0.21×
Q3 24
0.40×
Q2 24
0.34×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
IQST
IQST
Operating Cash FlowLast quarter
$-943.0K
$-1.2M
Free Cash FlowOCF − Capex
$-1.9M
$-1.2M
FCF MarginFCF / Revenue
-2.8%
-1.5%
Capex IntensityCapex / Revenue
1.4%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.7M
$-4.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
IQST
IQST
Q4 25
$-943.0K
$-1.2M
Q3 25
$2.2M
$-953.0K
Q2 25
$4.3M
$257.7K
Q1 25
$-16.8M
$-1.9M
Q4 24
$-3.0M
$-403.7K
Q3 24
$7.0M
$625.0K
Q2 24
$6.7M
$-2.6M
Q1 24
$-4.7M
$-536.9K
Free Cash Flow
INGN
INGN
IQST
IQST
Q4 25
$-1.9M
$-1.2M
Q3 25
$1.6M
$-969.2K
Q2 25
$3.7M
$211.7K
Q1 25
$-17.1M
$-2.0M
Q4 24
$-3.3M
$-421.3K
Q3 24
$5.3M
$594.5K
Q2 24
$6.6M
$-2.6M
Q1 24
$-6.1M
$-608.5K
FCF Margin
INGN
INGN
IQST
IQST
Q4 25
-2.8%
-1.5%
Q3 25
2.0%
-0.9%
Q2 25
4.6%
0.3%
Q1 25
-24.9%
-3.4%
Q4 24
-5.0%
-0.4%
Q3 24
7.1%
1.1%
Q2 24
8.9%
-3.4%
Q1 24
-9.6%
-1.2%
Capex Intensity
INGN
INGN
IQST
IQST
Q4 25
1.4%
0.0%
Q3 25
0.7%
0.0%
Q2 25
0.9%
0.1%
Q1 25
0.4%
0.1%
Q4 24
0.5%
0.0%
Q3 24
2.2%
0.1%
Q2 24
0.1%
0.0%
Q1 24
2.1%
0.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

IQST
IQST

USA$53.2M63%
Other$29.9M35%
Switzerland$1.1M1%

Related Comparisons